Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company
Go back to Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company| Amgen Inc (NASDAQ: AMGN) | Delayed: 354.91 +17.18 (5.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $337.73 | 52 Week High | $176.85 | |||
| Open | $342.91 | 52 Week Low | $133.64 | |||
| Day High | $355.58 | P/E | 53.45 | |||
| Day Low | $341.46 | EPS | $6.64 | |||
| Volume | 2,584,647 | |||||
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 57.14 +1.54 (2.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.60 | 52 Week High | $77.12 | |||
| Open | $55.94 | 52 Week Low | $49.03 | |||
| Day High | $57.28 | P/E | 37.10 | |||
| Day Low | $55.74 | EPS | $1.54 | |||
| Volume | 3,952,798 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
